Work

GSK3-targeted small molecules as therapies for Alzheimer’s disease

Year: 2026

Type: article

Abstract: Alzheimer’s disease (AD) is a progressive neurological disorder that affects memory, thinking, and behavior. It is one of the leading causes of dementia worldwide, and current treatments mainly focus on managing symptoms rather than slowing or stopping disease progress

Source: European Journal of Biomedical and Life Sciences

DOI: 10.29013/ejbls-26-1-33-45

Author: Krina Patel

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7155690398

FWCI:

Cites:

Cited by:

Related to: